Electromed Inc
8 nominees · 4 ballot items.
Electromed, Inc. annual meeting proposals include: (1) election of eight directors named in the proxy statement, (2) ratification of the appointment of RSM US LLP as independent registered public accounting firm for the fiscal year ending June 30, 2026, (3) advisory, non-binding approval of named executive officers’ compensation, and (4) advisory, non-binding vote on the frequency of future executive compensation votes (one year).
Follow how the vote landed and what changed on Electromed Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Directors
ManagementBoard: FORElection of eight director nominees to serve on the board.
- 2
Ratification of the Appointment of RSM US LLP as the Company's Independent Registered Public Accounting Firm for Fiscal 2026
ManagementBoard: FORRatify the appointment of RSM US LLP as the Company’s independent registered public accounting firm for fiscal 2026.
- 3
Advisory Approval of Executive Compensation
ManagementBoard: FORAdvisory (non-binding) approval of the compensation of the named executive officers as disclosed in the proxy statement.
- 4
Advisory Recommendation Regarding Frequency of Compensation Votes
ManagementBoard: FORAdvisory (non-binding) vote on how often future executive compensation votes should occur (every 1 year, every 2 years, or every 3 years).
Nominees on the ballot8
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | J.E. Simmons Co., P.C. | 6.0% | 492,822 | $12M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0% | 335,028 | $8M |
| 3 | BlackRock, Inc. | 2.8% | 229,332 | $5M |
| 4 | PUNCH ASSOCIATES INVESTMENT MANAGEMENT, INC.Activist | 2.7% | 224,520 | $5M |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 2.7% | 222,755 | $5M |
| 6 | TWO SIGMA INVESTMENTS, LP | 2.5% | 203,600 | $5M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 178,154 | $4M |
| 8 | DIMENSIONAL FUND ADVISORS LP | 2.0% | 167,708 | $4M |
| 9 | HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 1.8% | 150,800 | $4M |
| 10 | GAMCO INVESTORS, INC. ET AL | 1.7% | 142,000 | $3M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Electromed Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Electromed Inc 2025 annual meeting?
- Electromed Inc (ELMD) holds its 2025 annual shareholder meeting on Friday, November 14, 2025.
- What is the record date for the Electromed Inc 2025 meeting?
- The record date for the Electromed Inc 2025 meeting is Wednesday, September 17, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Electromed Inc's 2025 meeting?
- The board is presenting 8 director nominees at the Electromed Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Electromed Inc 2025 meeting?
- Shareholders will vote on 4 proposals at the Electromed Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.